
Ask a doctor about a prescription for LOSARTAN/HYDROCHLOROTHIAZIDE TEVA-RATIO 50/12.5 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Losartan/Hydrochlorothiazide Teva-ratio 50 mg/12.5 mg film-coated tablets
EFG
losartan potassium/
hydrochlorothiazide
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Losartan/Hydrochlorothiazide Teva is a combination of an angiotensin II receptor antagonist (losartan) and a diuretic (hydrochlorothiazide).
Angiotensin II is a substance produced in the body that binds to receptors in blood vessels, causing them to constrict. This results in an increase in blood pressure. Losartan prevents angiotensin II from binding to these receptors, causing the blood vessels to relax, which lowers blood pressure. Hydrochlorothiazide works by making the kidneys pass more water and salt. This also helps to reduce blood pressure.
Losartan/hydrochlorothiazide is indicated for the treatment of essential hypertension (high blood pressure).
Do not take Losartan/Hydrochlorothiazide Teva
Warnings and precautions
Consult your doctor or pharmacist before starting to take Losartan/Hydrochlorothiazide Teva tablets.
If you experience a decrease in vision or eye pain, these could be symptoms of fluid accumulation in the vascular layer of the eye (choroidal effusion) or an increase in eye pressure and can occur within a few hours to a few weeks after taking Losartan/Hydrochlorothiazide Teva. If left untreated, this can lead to permanent vision loss. You may be at greater risk if you have previously had an allergy to penicillin or sulphonamide.
Tell your doctor if you are pregnant (or think you might be). Losartan/Hydrochlorothiazide Teva is not recommended during the first trimester of pregnancy and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby.
It is essential that you inform your doctor before taking Losartan/Hydrochlorothiazide Teva:
Your doctor may monitor your kidney function, blood pressure and blood electrolyte levels (e.g. potassium) at regular intervals.
See also the information under the heading “Do not take Losartan/Hydrochlorothiazide Teva”.
Children and adolescents
There is no experience with the use of Losartan/Hydrochlorothiazide Teva in children. Therefore, Losartan/Hydrochlorothiazide Teva must not be given to children.
Elderly patients
Losartan/Hydrochlorothiazide Teva works as well and is as well tolerated by most elderly patients as by younger patients. Most elderly patients require the same dose as younger patients.
Other medicines and Losartan/Hydrochlorothiazide Teva
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
Tell your doctor if you are taking potassium supplements, salt substitutes that contain potassium, potassium-sparing medicines or other medicines that may increase potassium levels in the blood (e.g. trimethoprim-containing medicines), as combination with Losartan/Hydrochlorothiazide Teva is not recommended.
Diuretics like hydrochlorothiazide contained in Losartan/Hydrochlorothiazide Teva tablets may interact with other medicines. Preparations containing lithium should not be taken with Losartan/Hydrochlorothiazide Teva without close monitoring by your doctor. Special precautions (e.g. blood tests) may be necessary if you take potassium supplements, salt substitutes that contain potassium or potassium-sparing medicines, diuretics (water tablets), certain laxatives, glycyrrhizin (found in liquorice), medicines for treating gout, medicines for controlling heart rhythm or for diabetes (oral antidiabetics or insulin).
It is also important that your doctor knows if you are taking:
.
Your doctor may need to change your dose and/or take other precautions:
If you are taking an angiotensin-converting enzyme inhibitor (ACE inhibitor) or aliskiren (see also the information under the headings “Do not take Losartan/Hydrochlorothiazide Teva” and
“Warnings and precautions”).
Please, when taking Losartan/Hydrochlorothiazide Teva, inform your doctor when you are going to have an iodine-containing contrast medium.
Taking Losartan/Hydrochlorothiazide Teva with food, drinks and alcohol
It is recommended that you do not drink alcohol while taking these tablets: alcohol and Losartan/Hydrochlorothiazide Teva may increase the effects of each other.
Excessive salt in the diet may counteract the effect of Losartan/Hydrochlorothiazide Teva tablets.
You should avoid foods and drinks that contain liquorice, such as glycyrrhizin, which can cause abnormal blood electrolyte levels.
Losartan/Hydrochlorothiazide Teva can be taken with or without food.
Fertility, pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
You should inform your doctor if you are pregnant (or think you might be). Your doctor will normally advise you to stop taking Losartan/Hydrochlorothiazide Teva before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Losartan/Hydrochlorothiazide Teva. Losartan/Hydrochlorothiazide Teva is not recommended in early pregnancy and must not be taken after the third month of pregnancy, as it may cause serious harm to your baby.
Breast-feeding
Tell your doctor if you are breast-feeding or about to start breast-feeding. Losartan/Hydrochlorothiazide Teva is not recommended during breast-feeding, and your doctor will choose another treatment for you if you want to breast-feed.
Driving and using machines
When you start treatment with this medicine, you should not perform tasks that require special attention (e.g. driving a car or using dangerous machinery) until you know how your medicine affects you.
Losartan/Hydrochlorothiazide Teva contains lactose
If your doctor has told you that you have an intolerance to some sugars, contact them before taking this medicine.
Follow exactly the instructions of your doctor or pharmacist for taking this medicine. If you are not sure, ask your doctor or pharmacist again. Your doctor will decide the appropriate dose of losartan/hydrochlorothiazide, depending on your condition and whether you are taking other medicines. It is essential to keep taking losartan/hydrochlorothiazide while your doctor prescribes it to maintain constant control of your blood pressure.
High blood pressure
For most patients with high blood pressure, the usual dose is 1 tablet of losartan/hydrochlorothiazide 50 mg/12.5 mg per day to control blood pressure over 24 hours. This may be increased to 2 tablets of Losartan/Hydrochlorothiazide Teva 50 mg/12.5 mg per day or changed to 1 tablet of losartan/hydrochlorothiazide 100 mg/25 mg (a stronger dose) per day. The maximum daily dose is 2 tablets of 50 mg losartan/12.5 mg hydrochlorothiazide per day or 1 tablet of 100 mg losartan/25 mg hydrochlorothiazide per day.
Administration
The tablets should be swallowed whole with a glass of water.
If you take more Losartan/Hydrochlorothiazide Teva than you should
In case of overdose, contact your doctor immediately or go directly to the hospital for immediate medical attention. Overdose may cause a drop in blood pressure, palpitations, slow pulse, changes in blood composition and dehydration.
Inform your doctor or pharmacist immediately or call the Toxicology Information Service, telephone: 915 620 420, stating the medicine and the amount taken.
If you forget to take Losartan/Hydrochlorothiazide Teva
Try to take Losartan/Hydrochlorothiazide Teva at the prescribed time. However, if you miss a dose, do not take an extra dose. Simply return to your usual schedule.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
If you experience the following, stop taking Losartan/Hydrochlorothiazide Teva tablets and inform your doctor immediately or go to the emergency department of the nearest hospital:
A severe allergic reaction (skin rash, itching, swelling of the face, lips, mouth, or throat that can cause difficulty swallowing or breathing).
This is a serious but rare adverse effect, affecting more than 1 patient in 10,000, but less than 1 patient in 1,000. It may require urgent medical attention or hospitalization .
The following adverse effects have been reported:
Frequent: may affect up to 1 in 10 people
? cough, respiratory infection, nasal congestion, sinusitis, sinus disorders.
? diarrhea, abdominal pain, nausea, indigestion,
? muscle pain or cramps, leg pain, back pain,
? insomnia, headache, dizziness.
? weakness, fatigue, chest pain.
? high potassium levels (which can cause an abnormal heart rhythm), decreased hemoglobin levels
Infrequent: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
? hepatitis (liver inflammation), abnormal liver function tests
Frequency not known: frequency cannot be estimated from available data
Reporting of Adverse Effects
If you experience any of the adverse effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines, Website: www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep out of sight and reach of children.
Do not use this medicine after the expiration date stated on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not store above 25°C.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and any unused medicines in the pharmacy's SIGRE collection point. In case of doubt, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.
Composition of Losartan/Hydrochlorothiazide Teva-ratio Tablets
? The active ingredients are losartan potassium and hydrochlorothiazide. Each tablet contains
50 mg of losartan potassium and 12.5 mg of hydrochlorothiazide.
? The other ingredients are:
Core of the tablet: lactose monohydrate, microcrystalline cellulose (E460a), pregelatinized starch (from corn), magnesium stearate (E572).
Coating: polyvinyl alcohol, titanium dioxide (E171), macrogol 3350, talc (E553b),
yellow iron oxide (E172).
Appearance of Losartan/Hydrochlorothiazide Teva-ratio and Package Contents
? Losartan/Hydrochlorothiazide Teva-ratio 50 mg/12.5 mg film-coated tablets are yellow, oval, biconvex tablets marked with "5" and "0" on one side and a score line on both sides.
The tablet can be divided into equal doses.
The 50 mg/12.5 mg tablets are available in pack sizes of 1, 14, 20, 28,30, 56, 60, 84, 90, 98, and 100 tablets, calendar packs of 28 tablets, and hospital packs of 50x1 and 280 (10x28) tablets.
HDPE bottles with screw caps: 28, 100, 250, and clinical packs of 500 tablets.
Not all pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Teva Pharma, S.L.U.
C/ Anabel Segura 11. Edificio Albatros B, 1ª planta.
28108 Alcobendas. Madrid.
Manufacturer:
Pharmachemie B.V.
PO Box 552
2003 RN Haarlem
Netherlands
Teva Pharmaceutical Works Private Limited Company
Pallagi út 13, H-4042 Debrecen
Hungary
Teva Czech Industries s.r.o.
Ostravskà 29, 747 70 Opava-Komarov,
Czech Republic
Teva Pharma, S.L.U
C/ C, nº 4, Polígono Industrial Malpica,
50016 Zaragoza
Spain
This medicine is authorized in the Member States of the European Economic Area under the following names:
BE: | Co-Losartan TEVA 50 mg/12,5 mg film-coated tablets |
DK: | Losartan potassium/hydrochlorothiazide Teva 50/12,5 mg film-coated tablets |
FI: | Losatrix Comp 50 mg/12,5 mg film-coated tablets |
FR: | LOSARTAN/HCTZ Teva 50mg/12.5 mg, film-coated tablet |
DE: | Losartan comp AbZ 50 mg/12,5 mg film-coated tablets |
ES: | Losartan/Hydrochlorothiazide Teva 50 mg/12,5 mg film-coated tablets EFG |
HU: | Co-Arbartan 50 mg/12.5 mg film-coated tablet |
IE: | Losartan/hydrochlorothiazide TEVA 50/12.5 mg film-coated tablets |
IT: | Losartan/Idroclorotiazide TEVA 50/12,5 mg film-coated tablets |
NO: | Losartan/Hydrochlorothiazide Teva 50 mg/12,5 mg film-coated tablets |
PT: | Losartan + Hydrochlorothiazide Teva 50 mg + 12,5 mg tablets |
SE: | Losartan/Hydrochlorothiazide Teva 50 mg/12,5 mg film-coated tablets |
Date of the last revision of this leaflet: January 2025
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
You can access detailed and updated information about this medicine by scanning the QR code included in the packaging with your mobile phone (smartphone). You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/70595/P_70595.html
The average price of LOSARTAN/HYDROCHLOROTHIAZIDE TEVA-RATIO 50/12.5 mg FILM-COATED TABLETS in November, 2025 is around 2.92 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for LOSARTAN/HYDROCHLOROTHIAZIDE TEVA-RATIO 50/12.5 mg FILM-COATED TABLETS – subject to medical assessment and local rules.